Articles from Mitsui Chemicals, Inc.

Mitsui Chemicals, Inc. has announced that online applications for the 2026 Mitsui Chemicals Catalysis Science Award have been open since September 1, 2025. The application period will run from September 1 to December 25, 2025.

Mitsui Chemicals, Inc. (Tokyo: 4183; President & CEO: HASHIMOTO Osamu), a global chemicals manufacturer based in Japan, today announced the launch of its second Corporate Venture Capital Fund ‘321Catalyst™,’ as well as the establishment of a new subsidiary ‘321Catalyst Ventures, Inc.,’ which will manage the fund. Building on the success of its first fund, ‘321FORCE™,’ launched with Japanese venture capital Global Brain in 2022, 321Catalyst™’s mission will be to accelerate the building of global innovation partnerships and the launching of new products and business. Through the establishment of the new, independent fund in the USA, Mitsui Chemicals is doubling down on global investments in innovative startups that align with its strategic focus. Strong innovation partnerships with its portfolio companies will allow Mitsui Chemicals to launch new businesses ahead of the race. 321Catalyst™ will have a fund size of $60 million and a life of 10 years.

Mitsui Chemicals Catalysis Science Awards were established by Mitsui Chemicals in 2004 to recognize researchers who have made outstanding contributions to the progress in catalysis science. The awards consist of the Catalysis Science Award (the main award eligible for 47 years old or below) and the Catalysis Science Award for Creative Work (for younger generation at 37 years old or below). The awards are highly respected. The 2011 Catalysis Science Award winner later received the Nobel Prize in Chemistry in 2021.

Mitsui Chemicals, Inc. (Tokyo: 4183; President & CEO: HASHIMOTO Osamu) has developed the Diffrar™ array of polymer wafers for waveguides used in augmented reality (AR) glasses, with a view to expand into the augmented and virtual reality markets.

VECTRONTM T500 is a new IRS product containing TENEBENALTM, the world’s first meta-diamide active ingredient (IRAC Group 30) developed by Mitsui Chemicals Agro which has a different mode of action from existing vector control products.